DekaBank Deutsche Girozentrale Trims Holdings in Agilent Technologies, Inc. $A

DekaBank Deutsche Girozentrale cut its stake in Agilent Technologies, Inc. (NYSE:A) by 0.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 168,135 shares of the medical research company’s stock after selling 411 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.06% of Agilent Technologies worth $20,132,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the first quarter valued at $30,000. Ransom Advisory Ltd bought a new stake in Agilent Technologies during the first quarter valued at $32,000. Central Pacific Bank Trust Division bought a new stake in Agilent Technologies during the second quarter valued at $33,000. Zions Bancorporation National Association UT bought a new stake in Agilent Technologies during the first quarter valued at $38,000. Finally, Costello Asset Management INC bought a new stake in Agilent Technologies during the first quarter valued at $47,000.

Agilent Technologies Trading Up 0.2%

Shares of A stock opened at $146.01 on Thursday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The business has a 50-day moving average price of $129.24 and a two-hundred day moving average price of $118.56. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The firm has a market cap of $41.39 billion, a P/E ratio of 34.27, a price-to-earnings-growth ratio of 4.76 and a beta of 1.26.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the company posted $1.32 earnings per share. The company’s revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s payout ratio is 23.24%.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on A. JPMorgan Chase & Co. lifted their price objective on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. TD Cowen lifted their price objective on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Finally, UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $170.00 in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $149.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.